William Blair Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

William Blair Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.4M	Buy	+70,883	New	+$12.4M	0.04%	291

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

William Blair Investment Management's JAZZ Position: Q1 2026 in Review

William Blair Investment Management opened a new position in Jazz Pharmaceuticals (JAZZ) in Q1 2026: 70,883 shares worth $13.4M. The stake represents 0.04% of the portfolio and ranks #291 among its holdings.

571 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

William Blair Investment Management held 70,883 shares of Jazz Pharmaceuticals worth $13.4M as of Q1 2026.
Jazz Pharmaceuticals was a new William Blair Investment Management position in Q1 2026.
Jazz Pharmaceuticals made up 0.04% of William Blair Investment Management's portfolio in Q1 2026, its #291 holding.
571 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on William Blair Investment Management's 13F filing for Q1 2026, filed 8 May 2026.